Drug Type CAR-T |
Synonyms Allogeneic CAR-T targeting CD7 |
Target |
Mechanism CD7 inhibitors(T-cell antigen CD7 inhibitors) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Phase 1 | CN | 22 Jan 2020 | |
T-cell Acute Lymphoblastic Leukemia/Lymphoma | Phase 1 | CN | 22 Jan 2020 | |
T-Cell Lymphoma | Phase 1 | CN | 22 Jan 2020 | |
B-Cell Lymphoma | Discovery | CN | 23 Oct 2020 |